Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q2 2017 · 10-Q
Revenue$447.00K$447.00K+154.0% vs Q2 2016 Net Income-$936.00K-$936.00KN/M vs Q2 2016 EPS Diluted-$0.01-$0.01N/M vs Q2 2016 Operating Income-$1,404,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,272,000— Margins · derivedOperating margin-314.1%+969.4 pt vs Q2 2016
Net margin-209.4%+5984.9 pt vs Q2 2016
ended Jan 31, 2017 · filed Mar 2, 2017 · 30 d after period end